I’m on a Newer Weight Loss Drug. Should I Take a Supplement?

To say the excitement about newer weight loss drugs has reached a fever pitch would be an understatement. These drugs — including semaglutide (Wegovy and Ozempic), which are glucagon-like peptide-1 (GLP-1) receptor agonists, and tirzepatide (Zepbound and Mounjaro), which are dual GLP-1/GIP (glucose-dependent insulinotropic polypeptide) receptor agonists — are incredibly effective for weight loss, so it’s no wonder why.
We talked with two registered dietitians to find out.
What Do People Need to Know About the Side Effects of Newer Drugs Linked to Weight Loss?
Next up video playing in 10 seconds
Do You Need to Take a Supplement if You’re on a Weight Loss Drug?
It’s certainly possible, and your healthcare team can help you determine the answer based on your individual health. In general, though, anyone taking a GLP-1 should keep some key nutrition considerations in mind.
“These medications are well known to decrease the appetite, which itself causes people to take in fewer calories and possibly eat less balanced, nourishing foods,” says Beth Warren, a registered dietitian based in New York City.
What’s more, if you’re losing weight rapidly, that’s another reason you should be on guard for potential nutrient deficiencies and make sure you have your bases covered, says DeGore.
What Supplements Do You Need if You’re Taking a GLP-1?
Your doctor may recommend you take supplements in addition to steps such as eating smaller, more frequent meals; limiting foods high in added sugar and saturated fats; and prioritizing protein.
“Supplement means ‘in addition to.’ These are meant to assist, not replace, nutrients in your diet,” says Warren.
The supplements your doctor or registered dietitian might recommend address common deficiencies, particularly those that may arise during weight loss. Talk to your healthcare practitioner for more guidance on exactly how much you need to take. If you’re worried about a deficiency, ask your provider about testing.
Vitamin B12
Vitamin D
Probiotics
Multivitamin
A multivitamin won’t overcome poor dietary habits, but you can think of it as a security blanket, says Warren. Remember, though, that vitamins and minerals are more effectively absorbed through food than from a supplement, she adds.
The Bottom Line
The Takeaway
- GLP-1 and dual GIP/GLP-1 receptor agonists can help you lose weight by slowing digestion, reducing appetite, and quieting food noise. As a result, you may eat less.
- These medications may also cause uncomfortable gastrointestinal side effects like diarrhea, nausea, and vomiting. Between these symptoms and a reduced appetite, you may not get sufficient nutrients.
- Eating smaller, more frequent meals, adopting a high-protein, nutrient-dense diet, and taking supplements like a multivitamin, probiotic, vitamin B12, and vitamin D can help you stay healthy. Be sure to talk to your doctor before starting any supplement.
- Liu Y et al. The Weight-Loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-Diabetic Individuals With Overweight or Obesity: A Systematic Review With Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials . The American Journal of Clinical Nutrition. September 2023.
- Hayashi D et al. What Is Food Noise? A Conceptual Model of Food Cue Reactivity. Nutrients. November (II) 2023.
- GLP-1 Agonists. Cleveland Clinic. July 3, 2023.
- Butsch WS et al. Nutritional Deficiencies and Muscle Loss in Adults With Type 2 Diabetes Using GLP-1 Receptor Agonists: A Retrospective Observational Study. Obesity Pillars. September 2025.
- Mozaffarian D et al. Nutritional Priorities to Support GLP-1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society. Obesity Pillars. September 2025.
- Vitamin B12 Fact Sheet for Consumers. National Institutes of Health Office of Dietary Supplements. December 15, 2023.
- Vitamin D Fact Sheet for Consumers. National Institutes of Health Office of Dietary Supplements. November 8, 2022.
- Johnson BVB et al. Dietary Supplement Considerations During Glucagon-Like Peptide-1 Receptor Agonist Treatment: A Narrative Review. Obesity Pillars. December 2025.

Allison Buttarazzi, MD
Medical Reviewer
Allison Buttarazzi, MD, is board-certified in internal medicine and lifestyle medicine, and is a certified health and well-being coach. In her primary care practice, Dr. Buttarazzi focuses on lifestyle medicine to help her patients improve their health and longevity, and her passion is helping patients prevent and reverse chronic diseases (like heart disease, high blood pressure, and diabetes) by improving their lifestyle habits.
She is a graduate of Tufts University School of Medicine and completed a residency at Maine Medical Center. Diagnosed with celiac disease during medical school, she realized the power of improving one's health through diet and lifestyle habits, which she later incorporated into her practice.

Jessica Migala
Author
Jessica Migala is a freelance writer with over 15 years of experience, specializing in health, nutrition, fitness, and beauty. She has written extensively about vision care, diabetes, dermatology, gastrointestinal health, cardiovascular health, cancer, pregnancy, and gynecology. She was previously an assistant editor at Prevention where she wrote monthly science-based beauty news items and feature stories.
She has contributed to more than 40 print and digital publications, including Cosmopolitan, O:The Oprah Magazine, Real Simple, Woman’s Day, Women’s Health, Fitness, Family Circle, Health, Prevention, Self, VICE, and more. Migala lives in the Chicago suburbs with her husband, two young boys, rescue beagle, and 15 fish. When not reporting, she likes running, bike rides, and a glass of wine (in moderation, of course).